A PROSPECTIVE CLINICAL TRIAL COMPARING METRIZAMIDE AND IOHEXOL FOR EQUINE MYELOGRAPHY

A prospective clinical trial comparing adverse postmyelographic effects and myelographic quality of metrizamide and iohexol was conducted. Using a predetermined, randomized assignment, 24 horses exhibiting neurologic signs were administered either metrizamide (180 mgl/ml) or iohexol (180 mgl/ml) via...

Full description

Saved in:
Bibliographic Details
Published in:Veterinary radiology & ultrasound Vol. 39; no. 2; pp. 106 - 109
Main Authors: Widmer, William R., Blevins, William E., Jakovljevic, Samuel, Levy, Michel, Teclaw, Robert F., Han, Connie M., Hurd, Cheryl D.
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-03-1998
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A prospective clinical trial comparing adverse postmyelographic effects and myelographic quality of metrizamide and iohexol was conducted. Using a predetermined, randomized assignment, 24 horses exhibiting neurologic signs were administered either metrizamide (180 mgl/ml) or iohexol (180 mgl/ml) via cerebellomedullary puncture. Each horse was evaluated postmyelographically for adverse effects. Myelographic quality was assessed by a numerical scoring method. Adverse effects were observed more frequently with metrizamide (21) compared with iohexol (6) myelography (p < 0.05). Seizures, intensification of preexisting neurologic signs and prolonged anesthetic recovery were the most common complications after myelography. There was no difference in myelographic quality (p > 0.05). We conclude that iohexol is safer than metrizamide for equine myelography and that quality myelograms can be obtained with either contrast medium.
Bibliography:istex:25E8B8CF311AE62D17EA9FDEB97DDE64B1280E2A
ark:/67375/WNG-LBFQDS37-G
ArticleID:VRU106
The contrast media used in this study were provided by Nycomed, Inc., 101 Carnegie Center, Princeton, NJ.
ISSN:1058-8183
1740-8261
DOI:10.1111/j.1740-8261.1998.tb01974.x